UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 8.164

Sortiert nach

A 0.8-V 1.2-μW rail-to-rail fully differential OpAmp with adaptive biasing

2012 Proceedings of the ESSCIRC (ESSCIRC), 2012, p.77-80

2012

Link zum Volltext
IEEE_Xplore

084 Inhaled Doxycycline reduces allergen-induced airway inflammation, hyperresponsiveness and remodelling in mice

Revue des maladies respiratoires, 2005, Vol.22 (5), p.887-887

2005

Link zum Volltext

Verfügbarkeit prüfen

084 Inhaled Doxycycline reduces allergen-induced airway inflammation, hyperresponsiveness and remodelling in mice

Revue des maladies respiratoires, 2005-11, Vol.22 (5), p.887

2005

Link zum Volltext

Verfügbarkeit prüfen

1,4-Benzodiazepine-2,5-diones as small molecule antagonists of the HDM2–p53 interaction: discovery and SAR

Bioorganic & medicinal chemistry letters, 2005-02, Vol.15 (3), p.765-770

2005

Link zum Volltext

Verfügbarkeit prüfen

1.9% bi-axial tensile strain in thick germanium suspended membranes fabricated in optical germanium-on-insulator substrates for laser applications

Applied physics letters, 2015-11, Vol.107 (19)

2015

Link zum Volltext

Verfügbarkeit prüfen

1002P Impact of pharmacodynamic biomarkers in phase I immune-oncology trials

Annals of oncology, 2021-09, Vol.32, p.S849-S850

2021

Link zum Volltext

Verfügbarkeit prüfen

1013P - Incidental early occult ovarian cancer after risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers followed in a community public hospital

Annals of oncology, 2019-10, Vol.30, p.v414-v414

2019

Link zum Volltext

Verfügbarkeit prüfen

1013PIncidental early occult ovarian cancer after risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers followed in a community public hospital

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Link zum Volltext

Verfügbarkeit prüfen

1019O Clinical and translational data from the phase I SURPASS trial of ADP-A2M4CD8 T cell receptor (TCR) T cell therapy alone or combined with nivolumab in solid tumors

Annals of oncology, 2023-10, Vol.34, p.S620-S621

2023

Link zum Volltext

Verfügbarkeit prüfen

1030P Phase I, first-in-human trial evaluating the STING agonist BI 1387446 alone and in combination with ezabenlimab in solid tumors

Annals of oncology, 2023-10, Vol.34, p.S626-S626

2023

Link zum Volltext

Verfügbarkeit prüfen

1045P Safety and preliminary clinical activity of JNJ-78306358 (JNJ-358), an HLA-G and CD3 bispecific antibody, for the treatment of advanced stage solid tumor

Annals of oncology, 2023-10, Vol.34, p.S633-S634

2023

Link zum Volltext

Verfügbarkeit prüfen

1055 poster HIGH-DOSE NEOADJUVANT RADIOCHEMOTHERAPY FOLLOWED BY SURGERY IN MRI AND EUS-DEFINED POOR-RISK RECTAL CANCER

Radiotherapy and oncology, 2011, Vol.99, p.S393-S393

2011

Link zum Volltext

Verfügbarkeit prüfen

1064PA PHASE 1 STUDY OF ENADENOTUCIREV, AN ONCOLYTIC AD11/AD3 CHIMERIC GROUP B ADENOVIRUS, ADMINISTERED INTRAVENOUSLY - ANALYSIS OF DOSE EXPANSION AND REPEAT CYCLE COHORTS IN PATIENTS WITH METASTATIC COLORECTAL CANCER (MCRC)

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv367-iv367

2014

Link zum Volltext

Verfügbarkeit prüfen

1068P Rescue chemotherapy (CT) after immune-oncology (IO) drugs in patients (pts) with refractory solid tumours: A propensity score (PS) matched cohort study

Annals of oncology, 2020-09, Vol.31, p.S726-S727

2020

Link zum Volltext

Verfügbarkeit prüfen

1068PA PHASE 1 MECHANISM OF ACTION STUDY OF INTRA-TUMOURAL (IT) OR INTRAVENOUS (IV) ADMINISTRATION OF ENADENOTUCIREV, AN ONCOLYTIC AD11/AD3 CHIMERIC GROUP B ADENOVIRUS IN COLON CANCER PATIENTS UNDERGOING RESECTION OF PRIMARY TUMOUR

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv368-iv368

2014

Link zum Volltext

Verfügbarkeit prüfen

[107] Isolation and chemical estimation of α-isopropylmalate and β-isopropylmalate

Methods in Enzymology, 1970, Vol.17, p.791-793

1970

Link zum Volltext

Verfügbarkeit prüfen

1074TiP A phase I/II, open label, first-in-human, dose escalation and expansion study of SAR445877 administered as monotherapy in adults with advanced solid tumors

Annals of oncology, 2023-10, Vol.34, p.S646-S647

2023

Link zum Volltext

Verfügbarkeit prüfen

1085-196 The effects of aspirin on blood pressure in untreated hypertensive patients are dependent on the time of drug administration

Journal of the American College of Cardiology, 2004-03, Vol.43 (5), p.A483-A483

2004

Link zum Volltext

Verfügbarkeit prüfen

The 11 year solar cycle signal in transient simulations from the Whole Atmosphere Community Climate Model

Journal of Geophysical Research: Atmospheres, 2012-03, Vol.117 (D6), p.n/a

2012

Link zum Volltext

Verfügbarkeit prüfen

1101 Multimodality imaging in the assessment of pericardial malign disease

European heart journal cardiovascular imaging, 2020-01, Vol.21 (Supplement_1)

2020

Link zum Volltext

Verfügbarkeit prüfen

1121-54 Implications of the “watermelon seeding” phenomenon during coronary interventions for in-stent restenosis insights from the restenosis intrastent balloon angioplasty versus elective stenting (RIBS) randomized trial

Journal of the American College of Cardiology, 2004-03, Vol.43 (5), p.A78-A78

2004

Link zum Volltext

Verfügbarkeit prüfen

114P Retrospective analysis to validate the CTS5 in patients from El Álamo IV registry and GEICAM adjuvant studies

ESMO open, 2023-05, Vol.8 (1), p.101338, Article 101338

2023

Link zum Volltext

Verfügbarkeit prüfen

118O Definitive results for NSCLC and bladder cancer cohorts in the phase IIa trial of visugromab (CTL-002) in advanced/metastatic anti-PD/PD-L1 relapsed/refractory solid tumors (GDFATHER-trial)

Immuno-oncology technology, 2023-12, Vol.20, p.100590, Article 100590

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 8.164

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(6.995)
Mit Volltextzugriff
(7.041)

Publikationsform

6 weitere anzeigen...

Weniger anzeigen...

Sprache

9 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(4.045)
Life Sciences & Biomedicine
(2.877)
Humans
(2.370)
Male
(1.516)
Female
(1.465)
Biological And Medical Sciences
(914)
Adult
(912)
Middle Aged
(902)
Physical Sciences
(899)
Animals
(707)
Aged
(705)
Medical Sciences
(630)
Technology
(624)
Physics
(500)
Chemistry
(389)
Adolescent
(348)
Fundamental And Applied Biological Sciences. Psychology
(341)
Exact Sciences And Technology
(311)
Engineering
(286)
Child
(275)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

A 0.8-V 1.2-μW rail-to-rail fully differential OpAmp with adaptive biasing

084 Inhaled Doxycycline reduces allergen-induced airway inflammation, hyperresponsiveness and remodelling in mice

084 Inhaled Doxycycline reduces allergen-induced airway inflammation, hyperresponsiveness and remodelling in mice

1,4-Benzodiazepine-2,5-diones as small molecule antagonists of the HDM2–p53 interaction: discovery and SAR

1.9% bi-axial tensile strain in thick germanium suspended membranes fabricated in optical germanium-on-insulator substrates for laser applications

1002P Impact of pharmacodynamic biomarkers in phase I immune-oncology trials

1013P - Incidental early occult ovarian cancer after risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers followed in a community public hospital

1013PIncidental early occult ovarian cancer after risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers followed in a community public hospital

1019O Clinical and translational data from the phase I SURPASS trial of ADP-A2M4CD8 T cell receptor (TCR) T cell therapy alone or combined with nivolumab in solid tumors

1030P Phase I, first-in-human trial evaluating the STING agonist BI 1387446 alone and in combination with ezabenlimab in solid tumors

1035PINDUCTION CHEMOTHERAPY (ICT) WITH DOCETAXEL/CISPLATIN/5-FLUOROURACIL (T/P/F) FOLLOWED BY CHEMORADIOTHERAPY WITH CISPLATIN (CRTP) VS BIORADIOTHERAPY WITH CETUXIMAB (RTCX) FOR UNRESECTABLE LOCALLY ADVANCED HEAD & NECK CANCER (ULAHNC): PRELIMINARY RESULTS ON TOXICITY A TTCC GROUP TRIAL

1045P Safety and preliminary clinical activity of JNJ-78306358 (JNJ-358), an HLA-G and CD3 bispecific antibody, for the treatment of advanced stage solid tumor

1055 poster HIGH-DOSE NEOADJUVANT RADIOCHEMOTHERAPY FOLLOWED BY SURGERY IN MRI AND EUS-DEFINED POOR-RISK RECTAL CANCER

1064PA PHASE 1 STUDY OF ENADENOTUCIREV, AN ONCOLYTIC AD11/AD3 CHIMERIC GROUP B ADENOVIRUS, ADMINISTERED INTRAVENOUSLY - ANALYSIS OF DOSE EXPANSION AND REPEAT CYCLE COHORTS IN PATIENTS WITH METASTATIC COLORECTAL CANCER (MCRC)

1068P Rescue chemotherapy (CT) after immune-oncology (IO) drugs in patients (pts) with refractory solid tumours: A propensity score (PS) matched cohort study

1068PA PHASE 1 MECHANISM OF ACTION STUDY OF INTRA-TUMOURAL (IT) OR INTRAVENOUS (IV) ADMINISTRATION OF ENADENOTUCIREV, AN ONCOLYTIC AD11/AD3 CHIMERIC GROUP B ADENOVIRUS IN COLON CANCER PATIENTS UNDERGOING RESECTION OF PRIMARY TUMOUR

[107] Isolation and chemical estimation of α-isopropylmalate and β-isopropylmalate

1074TiP A phase I/II, open label, first-in-human, dose escalation and expansion study of SAR445877 administered as monotherapy in adults with advanced solid tumors

1085-196 The effects of aspirin on blood pressure in untreated hypertensive patients are dependent on the time of drug administration

The 11 year solar cycle signal in transient simulations from the Whole Atmosphere Community Climate Model

1101 Multimodality imaging in the assessment of pericardial malign disease

1121-54 Implications of the “watermelon seeding” phenomenon during coronary interventions for in-stent restenosis insights from the restenosis intrastent balloon angioplasty versus elective stenting (RIBS) randomized trial

114P Retrospective analysis to validate the CTS5 in patients from El Álamo IV registry and GEICAM adjuvant studies

1168P Clinical characteristics and survival in stage I-IIIA lung cancer resected patients in Spain, analyzed in the Thoracic Tumors Registry (TTR)

118O Definitive results for NSCLC and bladder cancer cohorts in the phase IIa trial of visugromab (CTL-002) in advanced/metastatic anti-PD/PD-L1 relapsed/refractory solid tumors (GDFATHER-trial)

Suchergebnisse filtern